Phase III combination trial improves survival in men with metastatic prostate cancer
A Phase III clinical trial has shown that metastatic prostate cancer improved through the use of a combination therapy with enzalutamide...
List view / Grid view
A Phase III clinical trial has shown that metastatic prostate cancer improved through the use of a combination therapy with enzalutamide...
Testing could lead to extension of life through improved clinical decision-making by identifying patients who need to switch from targeted hormonal therapy to chemotherapy...
Researchers believe the combination with established treatment could improve outcomes in prostate cancer...